AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30929268 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 29202751 — intervention group
Group type: EXPERIMENTAL
Intervention: Walnut-enriched reduced-energy diet (15% of energy)
Number of subjects: 100
Study 29202751 — intervention group
Group type: COMPARATOR
Intervention: Standard reduced-energy-density diet
Number of subjects: 100
Study 29202751 — intervention group
Group type: EXPERIMENTAL
Intervention: Walnut-enriched reduced-energy diet
Number of subjects: 100
Study 29202751 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 25546052 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetazoline
Number of subjects: 8
Study 25546052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 22872323 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 ml simple olive oil (OO)
Number of subjects: 82
Study 22872323 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 ml EGCG-supplemented olive oil (OO)
Number of subjects: 82
Study 21167906 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-emotional sensitization through repetitive presentation of disorder-related pictures
Number of subjects: 25
Study 21167906 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 25
Study 19880052 — intervention group
Group type: EXPERIMENTAL
Intervention: research-HSA (r-HSA)
Number of subjects: 191
Study 19880052 — intervention group
Group type: COMPARATOR
Intervention: clinical HSA (c-HSA)
Number of subjects: 191
Study 19880052 — intervention group
Group type: EXPERIMENTAL
Intervention: research-HSA (r-HSA) and clinical HSA (c-HSA)
Number of subjects: 191
Study 19926959 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced labor ward-based services for PMTCT (opt-in HIV testing and NVP administration)
Number of subjects: 7664
Study 19926959 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 7664
Study 19926959 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced labor ward-based services for PMTCT
Number of subjects: 7664
Study 16111901 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 24
Study 16111901 — intervention group
Group type: EXPERIMENTAL
Intervention: SNP (sodium nitro-prusside)
Number of subjects: 24
Study 16111901 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 24
Study 16111901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 11818429 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking program (6 months)
Number of subjects: 16
Study 11818429 — intervention group
Group type: COMPARATOR
Intervention: Non-walking control group
Number of subjects: 16
Study 10194693 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic tropisetron 5 mg orally before anesthesia
Number of subjects: 68
Study 10194693 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 68
Study 8531404 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic examination
Number of subjects: 31
Study 2325217 — intervention group
Group type: COMPARATOR
Intervention: Unna's compressive boots
Number of subjects: 28
Study 2325217 — intervention group
Group type: EXPERIMENTAL
Intervention: Unna's compressive boots and sclerotherapy with 3% sodium tetradecyl sulfate (Sotradecol)
Number of subjects: 28
Study 7373798 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care book and optional seminar
Number of subjects: 699
Study 7373798 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care book with financial incentive ($50 for reduced visits)
Number of subjects: 699
Study 7373798 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 699
Study 29934378 — intervention group
Group type: EXPERIMENTAL
Intervention: Gynaecology Teaching Associate (GTA) teaching
Number of subjects: 492
Study 29934378 — intervention group
Group type: COMPARATOR
Intervention: Conventional manikin teaching
Number of subjects: 492
Study 27451818 — intervention group
Group type: EXPERIMENTAL
Intervention: DOTS Category I treatment plus prednisolone 1mg/kg for first 4 weeks, then tapered down
Number of subjects: 120
Study 27451818 — intervention group
Group type: COMPARATOR
Intervention: DOTS Category I treatment plus placebo
Number of subjects: 120
Study 27451818 — intervention group
Group type: EXPERIMENTAL
Intervention: DOTS Category I treatment plus prednisolone
Number of subjects: 120
Study 24213955 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 hours of rehabilitation treatment including aerobic exercise for 28 days (Group 1)
Number of subjects: 30
Study 24213955 — intervention group
Group type: COMPARATOR
Intervention: Not therapy (control; Group 2)
Number of subjects: 30
Study 22421093 — intervention group
Group type: EXPERIMENTAL
Intervention: Limbal marked group
Number of subjects: 200
Study 22421093 — intervention group
Group type: COMPARATOR
Intervention: Unmarked group
Number of subjects: 200
Study 20090328 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin infiltration (etched for 5 s with 37% H(3)PO(4) and infiltrated twice for 60 s)
Number of subjects: 104
Study 20090328 — intervention group
Group type: COMPARATOR
Intervention: Positive control (fissure sealant applied to one lesion)
Number of subjects: 104
Study 20090328 — intervention group
Group type: COMPARATOR
Intervention: Untreated control (no treatment applied)
Number of subjects: 104
Study 18565980 — intervention group
Group type: EXPERIMENTAL
Intervention: FROP-Com
Number of subjects: 344
Study 18565980 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed Up and Go (TUG)
Number of subjects: 344
Study 18565980 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Reach (FR)
Number of subjects: 344
Study 16002181 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release chlorhexidine dressing
Number of subjects: 112
Study 16002181 — intervention group
Group type: COMPARATOR
Intervention: Standard dressing regimen (control)
Number of subjects: 112
Study 11974977 — intervention group
Group type: EXPERIMENTAL
Intervention: Pericranial injection of 10 x 20 MU DYSPORT
Number of subjects: 21
Study 11974977 — intervention group
Group type: COMPARATOR
Intervention: Injection of isotonic saline (placebo)
Number of subjects: 21
Study 10527096 — intervention group
Group type: EXPERIMENTAL
Intervention: Plaster cast socket with silicone sleeve
Number of subjects: 56
Study 10527096 — intervention group
Group type: COMPARATOR
Intervention: Elastic compression bandages (control)
Number of subjects: 56
Study 7574314 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 49
Study 7574314 — intervention group
Group type: COMPARATOR
Intervention: Control group (lower limb surgery)
Number of subjects: 49
Study 7574314 — intervention group
Group type: EXPERIMENTAL
Intervention: Open cholecystectomy (OC)
Number of subjects: 49
Study 7574314 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (OC, LC, control)
Number of subjects: 49
Study 2188845 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 micrograms cyclopenthiazide
Number of subjects: 8
Study 2188845 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 micrograms cyclopenthiazide
Number of subjects: 8
Study 2188845 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 6971940 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-inflammatory analgesics
Number of subjects: 60
Study 6971940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 31202921 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime/avibactam (CAZ‐AVI)
Number of subjects: 5000
Study 31202921 — intervention group
Group type: COMPARATOR
Intervention: Imipenem
Number of subjects: 5000
Study 28753799 — intervention group
Group type: EXPERIMENTAL
Intervention: CellDetect assay
Number of subjects: 217
Study 28753799 — intervention group
Group type: COMPARATOR
Intervention: BTA stat
Number of subjects: 217
Study 28753799 — intervention group
Group type: COMPARATOR
Intervention: Standard urine cytology
Number of subjects: 217
Study 28753799 — intervention group
Group type: COMPARATOR
Intervention: True negative cases
Number of subjects: 217
Study 26964827 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized magnesium sulfate (3 ml of 260 mmol/L solution every 20 to 60 minutes)
Number of subjects: 50
Study 26964827 — intervention group
Group type: COMPARATOR
Intervention: Control group treated with nebulized saline as a placebo in addition to standard protocol
Number of subjects: 50
Study 25251929 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic exercise training (16.5% O2, n=10)
Number of subjects: 19
Study 25251929 — intervention group
Group type: COMPARATOR
Intervention: Normoxic exercise training (21% O2, n=9)
Number of subjects: 19
Study 25251929 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Hypoxic and Normoxic)
Number of subjects: 19
Study 21981682 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 2.5 mg
Number of subjects: 606
Study 21981682 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg
Number of subjects: 606
Study 21981682 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 606
Study 20564607 — intervention group
Group type: EXPERIMENTAL
Intervention: Alverine citrate 120 mg capsule
Number of subjects: 0
Study 17013645 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (1 mg intravenously every 3 months for a total of four doses)
Number of subjects: 29
Study 17013645 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 age- and sex-matched healthy blood donors)
Number of subjects: 29
Study 16119667 — intervention group
Group type: EXPERIMENTAL
Intervention: Support Team Assessment Schedule (STAS)
Number of subjects: 50
Study 16119667 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotterdam Symptom Checklist (RSCL)
Number of subjects: 50
Study 16119667 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of physical state after treatment
Number of subjects: 50
Study 11124916 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin A supplementation (5000 IU/day)
Number of subjects: 154
Study 11124916 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 9701528 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimebutine (50 mg intravenous injection)
Number of subjects: 15
Study 8029677 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative intravenous cholangiography
Number of subjects: 100
Study 8029677 — intervention group
Group type: COMPARATOR
Intervention: No preoperative intravenous cholangiography
Number of subjects: 100
Study 2597447 — intervention group
Group type: EXPERIMENTAL
Intervention: PTFE-sil
Number of subjects: 30
Study 2597447 — intervention group
Group type: COMPARATOR
Intervention: PTFE
Number of subjects: 30
Study 30875348 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapatinib 1000 mg daily with eribulin 1.23 mg/m (split-dose arm) days 1+8 every 21 days
Number of subjects: 43
Study 30875348 — intervention group
Group type: EXPERIMENTAL
Intervention: Eribulin 1.76 mg/m (3-weekly arm) day 1 every 21 days
Number of subjects: 43
Study 30695420 — intervention group
Group type: EXPERIMENTAL
Intervention: Qingshen Granule (QG), 1 package each time, 3 times per day for 8 weeks
Number of subjects: 63
Study 30695420 — intervention group
Group type: COMPARATOR
Intervention: Basic treatment of Western medicine (WM) and retention enema of Chinese medicine (CM)
Number of subjects: 63
Study 26089547 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (60 min cycling at 70% of peak oxygen uptake)
Number of subjects: 20
Study 26089547 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 20
Study 23489396 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy
Number of subjects: 1254
Study 23489396 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 1254
Study 21624541 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (6 g/day for a mean of 40 ± 12 days)
Number of subjects: 36
Study 21624541 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 19364997 — intervention group
Group type: EXPERIMENTAL
Intervention: ATP III intervention
Number of subjects: 68
Study 19364997 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (JNC‐7)
Number of subjects: 68
Study 16682588 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (daily administration for 7 days)
Number of subjects: 12
Study 16682588 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (90 minutes after administration)
Number of subjects: 12
Study 16682588 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (90 minutes and 7 days after administration)
Number of subjects: 12
Study 16682588 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (after 7 days)
Number of subjects: 12
Study 15292751 — intervention group
Group type: COMPARATOR
Intervention: Concentric training at 30 degrees x s(‐1) (G1)
Number of subjects: 55
Study 15292751 — intervention group
Group type: COMPARATOR
Intervention: Concentric training at 90 degrees x s(‐1) (G2)
Number of subjects: 55
Study 15292751 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training at 30 degrees x s(‐1) (G3)
Number of subjects: 55
Study 15292751 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training at 90 degrees x s(‐1) (G4)
Number of subjects: 55
Study 15292751 — intervention group
Group type: EXPERIMENTAL
Intervention: Training within 30‐60 degrees of knee flexion (all groups)
Number of subjects: 55
Study 11406520 — intervention group
Group type: EXPERIMENTAL
Intervention: D2E7 (anti-TNF monoclonal antibody)
Number of subjects: 50
Study 11406520 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 9761518 — intervention group
Group type: COMPARATOR
Intervention: CAPD
Number of subjects: 45
Study 9761518 — intervention group
Group type: EXPERIMENTAL
Intervention: CCPD
Number of subjects: 45
Study 9761518 — intervention group
Group type: EXPERIMENTAL
Intervention: TPD (tidal 50%)
Number of subjects: 45
Study 9761518 — intervention group
Group type: EXPERIMENTAL
Intervention: TPD (tidal 25%)
Number of subjects: 45
Study 7810814 — intervention group
Group type: EXPERIMENTAL
Intervention: Ointment containing two antibiotics
Number of subjects: 77
Study 7810814 — intervention group
Group type: EXPERIMENTAL
Intervention: Ointment containing one antibiotic plus hydrocortisone
Number of subjects: 77
Study 7810814 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 77
Study 2974095 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic human ANP (102-126) at 0.015 microgram/kg/min
Number of subjects: 8
Study 2974095 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic human ANP (102-126) at 0.20 microgram/kg/min
Number of subjects: 8
Study 2974095 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic human ANP (102-126)
Number of subjects: 8
Study 31903697 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 0
Study 31903697 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine 100 units/mL
Number of subjects: 0
Study 29229352 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracranial pressure monitoring in severe TBI
Number of subjects: 550
Study 29229352 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Glasgow Coma Scale motor score
Number of subjects: 550
Study 29229352 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural hematoma
Number of subjects: 550
Study 29229352 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced age
Number of subjects: 550
Study 29229352 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisternal effacement
Number of subjects: 550
Study 29229352 — intervention group
Group type: EXPERIMENTAL
Intervention: Study site
Number of subjects: 550
Study 29229352 — intervention group
Group type: EXPERIMENTAL
Intervention: Race
Number of subjects: 550
Study 27513601 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethmoid crest resection during electrocoagulation of the sphenopalatine artery
Number of subjects: 42
Study 27513601 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ethmoid crest resection)
Number of subjects: 42
Study 26571890 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy of auricular point sticking and Xiaopijian
Number of subjects: 91
Study 26571890 — intervention group
Group type: COMPARATOR
Intervention: Xiaopijian (control group)
Number of subjects: 91
Study 24260195 — intervention group
Group type: EXPERIMENTAL
Intervention: FMP2.1/AS02A vaccine
Number of subjects: 400
Study 24260195 — intervention group
Group type: COMPARATOR
Intervention: Control rabies vaccine
Number of subjects: 400
Study 21553262 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency stimulation (LFS) applied to the low back (ExpBack)
Number of subjects: 33
Study 21553262 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency stimulation (LFS) applied to the center of the RF (ExpArm)
Number of subjects: 33
Study 18450889 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-oxygen group (fraction of inspired oxygen: 30%)
Number of subjects: 0
Study 18450889 — intervention group
Group type: COMPARATOR
Intervention: High-oxygen group (fraction of inspired oxygen: 90%)
Number of subjects: 0
Study 18450889 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-oxygen group
Number of subjects: 0
Study 18450889 — intervention group
Group type: COMPARATOR
Intervention: High-oxygen group
Number of subjects: 0
Study 16926619 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders (CYBOCS-PDD)
Number of subjects: 172
Study 12151898 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression hip screw
Number of subjects: 426
Study 12151898 — intervention group
Group type: COMPARATOR
Intervention: Gamma nail
Number of subjects: 426
Study 12151898 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 426
Study 10546006 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin treatment
Number of subjects: 3438
Study 7799013 — intervention group
Group type: EXPERIMENTAL
Intervention: MVPP
Number of subjects: 89
Study 7799013 — intervention group
Group type: COMPARATOR
Intervention: ChIVPP/EVA
Number of subjects: 89
Study 1689740 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (doses of 0.2-80 mg)
Number of subjects: 0
Study 520385 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG alpha rhythm and refractory period model
Number of subjects: 20
Study 6866590 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (MCT) in a high-calcium and vitamin D-containing formula (50% of fat as MCT)
Number of subjects: 20
Study 6866590 — intervention group
Group type: COMPARATOR
Intervention: Long-chain triglycerides in a similar formula (control group)
Number of subjects: 20
Study 30696786 — intervention group
Group type: EXPERIMENTAL
Intervention: 2017 agreement language
Number of subjects: 820
Study 30696786 — intervention group
Group type: EXPERIMENTAL
Intervention: Stricter language
Number of subjects: 820
Study 30696786 — intervention group
Group type: COMPARATOR
Intervention: Original NAS advertising text
Number of subjects: 820
Study 30400934 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month malaria chemoprevention (PMC) with monthly 3-day treatment courses of dihydroartemisinin-piperaquine at 2, 6, and 10 weeks after discharge
Number of subjects: 1040
Study 30400934 — intervention group
Group type: COMPARATOR
Intervention: Standard in-hospital care plus a single 3-day treatment course with artemether-lumefantrine at discharge
Number of subjects: 1040
Study 27634079 — intervention group
Group type: EXPERIMENTAL
Intervention: Core strength training (CST)
Number of subjects: 20
Study 27634079 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 20
Study 24799520 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial antiepileptic treatment
Number of subjects: 0
Study 24799520 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG characteristics prior to treatment
Number of subjects: 0
Study 22381025 — intervention group
Group type: EXPERIMENTAL
Intervention: Encapsulated supplement of fruit and vegetable juice concentrate (FVJC) for 6 months
Number of subjects: 30
Study 22381025 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules for 6 months
Number of subjects: 30
Study 20847903 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Activity Program (TAP)
Number of subjects: 60
Study 18046109 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan/HCTZ 300/25 mg once daily for 7 to 8 weeks
Number of subjects: 796
Study 15272291 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure measurement in the eye clinic
Number of subjects: 106
Study 15272291 — intervention group
Group type: COMPARATOR
Intervention: Home blood pressure measurement (HBPM)
Number of subjects: 106
Study 15272291 — intervention group
Group type: COMPARATOR
Intervention: Ambulatory blood pressure measurement (ABPM)
Number of subjects: 106
Study 15272291 — intervention group
Group type: COMPARATOR
Intervention: Diabetic clinic BP measurements
Number of subjects: 106
Study 15272291 — intervention group
Group type: COMPARATOR
Intervention: Tropicamide 1% and phenylephrine 2.5% eye drops
Number of subjects: 106
Study 12389836 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic detection and multidisciplinary care of delirium
Number of subjects: 227
Study 12389836 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 227
Study 10549460 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion, 1 mg kg‐1 min‐1 intravenous for 2 min, followed by propofol infusion, 200 micrograms kg‐1 min‐1
Number of subjects: 68
Study 10549460 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl bolus, 1 microgram kg‐1 intravenous + propofol infusion as in Group P
Number of subjects: 68
Study 10549460 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl bolus, 2 micrograms kg‐1 intravenous + propofol infusion as in Group P
Number of subjects: 68
Study 10549460 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl bolus, 3 micrograms kg‐1 intravenous + propofol infusion as in Group P
Number of subjects: 68
Study 10549460 — intervention group
Group type: EXPERIMENTAL
Intervention: Bispectral index values in nonmovement vs. movement category
Number of subjects: 68
Study 10549460 — intervention group
Group type: EXPERIMENTAL
Intervention: Bispectral index and 95% spectral edge frequency monitoring
Number of subjects: 68